Doximity, Inc. Class A Common Stock (DOCS)
Technology › Services-Computer Programming Services
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 58% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- Strong ROE of 26.5% with 37.7% net margin
- Revenue growing at 13% annually
Doximity, Inc. Class A Common Stock (DOCS) is a Technology company operating in Services-Computer Programming Services, listed on the NYSE , with a market capitalisation of $3.7 billion . Key value metrics: P/E ratio 14.5, P/B ratio 3.85, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Doximity, Inc. Class A Common Stock — Fundamental Analysis Summary
Doximity, Inc. Class A Common Stock (DOCS) is currently trading 58% above its Graham Number of $12.69, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a reasonable trailing P/E ratio of 14.5x.
On financial health, DOCS shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 26.5% (sector average: -1.0%), and minimal leverage with a debt-to-equity ratio of 0.18.
StockPik's composite Value Score for DOCS is 89/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
DOCS reports a high gross margin of 90.3% (sector average: 40.2%) and a strong operating margin of 40.4%.
DOCS shows revenue growing at 13% year-over-year, with earnings declining at 12%.